Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanuka honey versus aciclovir for herpes labialis
ACTRN12615000648527Phase 3Completed
- Sponsor
- HoneyLab
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aciclovir in herpes labialis (2 arms), sponsored by HoneyLab. Primary endpoint: Healing time from randomization to return to normal skin. Started Sep 2015; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on ACTRN12615000648527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000648527.